Global toUS Expansion Cromos Pharma operates with a strong international footprint including a US HQ and European presence, suggesting opportunities to upsell cross-border CRO services, streamline multi-region trials, and support global regulatory submissions through FDA and EMA-aligned processes.

HighEnrollment Expertise With 95 percent of trials achieving enrollment timelines and expertise in rapid patient recruitment across diverse regions, there are sales angles for sponsors needing faster study starts and reliable enrollment to meet aggressive trial timelines.

Therapeutic Range Experience across biosimilars, generics, and novel therapeutics across multiple indications indicates versatility to partner with sponsors at various stages of product development, including complex oncology and biologics programs.

Quality & Compliance Recent hires in global quality and compliance and a track record of FDA and EMA inspections position Cromos as a trusted partner for sponsors prioritizing robust quality systems and audit-ready data for high-stakes trials.

Strategic Partnerships Recent collaborations and regional market growth, including a Lisbon expansion and regional leadership appointments, signal opportunities to engage around site management, patient recruitment acceleration, and integrated regulatory affairs offerings in Europe and beyond.